Symbol="NRXP"
AssetType="Common Stock"
Name="NRX Pharmaceuticals Inc"
Description="NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware."
CIK="1719406"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="27420800"
EBITDA="-38061000"
PERatio="None"
PEGRatio="None"
BookValue="-0.004"
DividendPerShare="0"
DividendYield="0"
EPS="-0.54"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.728"
ReturnOnEquityTTM="-2.378"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.555"
EVToRevenue="-"
EVToEBITDA="-0.613"
Beta="0.844"
num_52WeekHigh="1.54"
num_52WeekLow="0.36"
num_50DayMovingAverage="0.551"
num_200DayMovingAverage="0.844"
SharesOutstanding="70310000"
DividendDate="None"
ExDividendDate="None"
symbol="NRXP"
open="0.38"
high="0.40"
low="0.37"
price="0.37"
volume="441548.00"
latest_trading_day="2023-07-25"
previous_close="0.39"
change="-0.02"
change_percent="-4.8718%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="287119"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.92"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="1153"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
